Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000097

Chief Scientific Officer sold 4,304 shares at an average $5.18 ($22,284)

  • Chief Scientific Officer acquired 4,304 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Moreadith Randall Chief Scientific Officer 2025-08-18 Option exercise 10b5-1 +2,227 $0.06 $134 2,227 D
Moreadith Randall Chief Scientific Officer 2025-08-18 Sale 10b5-1 −2,227 $5.25 $11,692 0 D
Moreadith Randall Chief Scientific Officer 2025-08-20 Option exercise 10b5-1 +2,077 $0.06 $125 2,077 D
Moreadith Randall Chief Scientific Officer 2025-08-20 Sale 10b5-1 −2,077 $5.10 $10,593 0 D
Derivatives
Moreadith Randall Chief Scientific Officer 2025-08-18 Option exercise · Stock Option (right to buy) 10b5-1 −2,227 471,263 D
Moreadith Randall Chief Scientific Officer 2025-08-20 Option exercise · Stock Option (right to buy) 10b5-1 −2,077 469,186 D
Open-market sales · 4,304 sh · avg $5.18 · $22,284
Loading xslF345X05/wk-form4_1755724400.xml…